this work references cited by second hopCited by
- 2020Screening Blood Donors for HIV, HCV, and HBV at the American Red Cross: 10-Year Trends in Prevalence, Incidence, and Residual Risk, 2007 to 201678 cited
- 2018Assessment of HIV transfusion transmission risk in South Africa: a 10‐year analysis following implementation of individual donation nucleic acid amplification technology testing and donor demographics eligibility changes55 cited
- 2021HIV, HCV, and HBV incidence and residual risk in US blood donors before and after implementation of the 12‐month deferral policy for men who have sex with men52 cited
- 2013Prevalence of human immunodeficiency virus RNA and antibody in first‐time, lapsed, and repeat blood donations across five international regions and relative efficacy of alternative screening scenarios50 cited
- 2017Residual risk of HIV, HCV and HBV in Canada45 cited
- 2012Reduction of the risk of transfusion‐transmitted viral infection by nucleic acid amplification testing in the Western Cape of South Africa: a 5‐year review39 cited
- 2017Sensitivity and specificity of a new automated system for the detection of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus nucleic acid in blood and plasma donations39 cited
Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work